{"id":20480,"date":"2022-11-08T07:56:27","date_gmt":"2022-11-08T12:56:27","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20480"},"modified":"2022-11-08T07:56:28","modified_gmt":"2022-11-08T12:56:28","slug":"new-va-study-finds-paxlovid-may-cut-the-risk-of-long-covid","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20480","title":{"rendered":"New VA study finds Paxlovid may cut the risk of long COVID"},"content":{"rendered":"\n<p>(By Pien Huang for NPR)<\/p>\n\n\n\n<p>It&#8217;s well-documented that Paxlovid \u2014 a 5-day course of antiviral pills from Pfizer \u2014 can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop severe illness.  Continue reading <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2022\/11\/08\/1134982401\/new-va-study-finds-paxlovid-may-cut-the-risk-of-long-covid\" data-type=\"URL\" data-id=\"https:\/\/www.npr.org\/sections\/health-shots\/2022\/11\/08\/1134982401\/new-va-study-finds-paxlovid-may-cut-the-risk-of-long-covid\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"54\" class=\"wp-image-3902\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Pien Huang for NPR) It&#8217;s well-documented that Paxlovid \u2014 a 5-day course of antiviral pills from Pfizer \u2014 can<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52,15],"tags":[75,173,237],"class_list":["post-20480","post","type-post","status-publish","format-standard","hentry","category-pandemic","category-part-dprescription-drugs","tag-covid-19","tag-long-covid-19","tag-paxlovid"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20480"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20480\/revisions"}],"predecessor-version":[{"id":20481,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20480\/revisions\/20481"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}